by Sue Robbins | Nov 12, 2020 | Migraine
Novartis announced positive results from a phase 4 study comparing treatment with erenumab (Aimovig), a calcitonin gene-related peptide (CGRP) receptor antagonist, to topiramate in patients with episodic and chronic migraine. The randomized, double-blind,...
by Sue Robbins | Nov 10, 2020 | Migraine
Many people who get migraines experience worsening symptoms during extreme weather changes, hot or humid summer weather, or changes in barometric pressure. Several studies attempting to find a scientific correlation between weather and migraines have yielded...
by Sue Robbins | Nov 9, 2020 | Wellness
It’s been a year of sacrifice, social distancing and skyrocketing stress. Can we at least enjoy Thanksgiving? In terms of risk, the timing of the Thanksgiving holiday couldn’t be worse. The coronavirus is raging across the country, setting new daily infection records....
by Sue Robbins | Nov 3, 2020 | Migraine
“Can you draw me a picture of your headache?” may sound like an unusual question – but drawings of headache pain provide plastic surgeons with valuable information on which patients are more or less likely to benefit from surgery to alleviate migraine headaches....
by Sue Robbins | Nov 2, 2020 | Wellness
Can’t concentrate? Losing sleep? Binge-eating your feelings? In a year of unprecedented stress, the nation collectively appears to be heading toward peak anxiety this week. People are sharing stories of stress eating, clearing their calendars (who could sit through a...
